Help us raise $3,000 to support Glaucoma NZ
We’re taking part in Round the Bays Auckland 2026 to help raise essential funds for the important work of Glaucoma New Zealand.
The first iStent InfiniteTM surgery in Australasia was performed at Auckland Eye in July 2022 as part of a clinical research study being sponsored by GLAUKOS Corporation and led in New Zealand by Dr Dean Corbett.
The iStent InfiniteTM is an investigational device designed to reduce elevated intraocular pressure in patients with open-angle glaucoma.
If you have any questions, please feel free to contact our clinical research department at research@aucklandeye.co.nz.

We’re taking part in Round the Bays Auckland 2026 to help raise essential funds for the important work of Glaucoma New Zealand.

Auckland Eye is proud to be the first centre in New Zealand participating in the Phase 3 CoMpass clinical trial.

Auckland Eye has become the very first site worldwide to recruit and treat a patient in the i-SIGHT2 study.